豚鼠皮内接种卡介苗后颈部淋巴结产生免疫调节细胞
该研究在豚鼠耳背皮内接种卡介苗(BCG)后,观察引流颈部淋巴结中的免疫调节细胞。全淋巴结细胞对可溶性分枝杆菌抗原(PPD或leprosin)体外不增殖,但去除尼龙毛黏附细胞后T细胞对PPD增殖,加入低至20%黏附细胞可使增殖下降83%,且需T细胞与巨噬细胞共同存在才发挥抑制。
要点
- 皮内接种BCG后引流淋巴结存在抑制性细胞群
- 全淋巴结细胞对可溶性抗原不应答但对抗原菌体应答
- 黏附细胞中T细胞与巨噬细胞共同介导抑制
核心结论
- 豚鼠皮内接种BCG后颈部引流淋巴结中存在免疫调节细胞,可抑制针对可溶性分枝杆菌抗原的T细胞增殖。
研究设计与样本
- 实验研究:豚鼠耳背皮内接种BCG,取颈部引流淋巴结细胞进行体外增殖实验。
主要发现
- 全颈部淋巴结细胞在可溶性分枝杆菌抗原(PPD或leprosin)存在下体外不增殖,但对全分枝杆菌有应答。
- 尼龙毛柱分离的非黏附T细胞在自体抗原呈递细胞存在下对PPD增殖。
- 加入低至20%尼龙毛黏附细胞可使上述增殖急剧下降83%。
- 黏附细胞中T细胞富集组分或巨噬细胞富集组分单独均无抑制效果,需两者共同存在才介导抑制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This work demonstrates the presence of immune regulatory cells in the cervical lymph nodes draining Bacillus Calmette-Guérin (BCG) vaccinated site on the dorsum of the ear in guinea pigs. It is shown that whole cervical lymph node cells did not proliferate in vitro in the presence of soluble mycobacterial antigens (PPD or leprosin) despite being responsive to whole mycobacteria. Besides, T cells from these lymph nodes separated as a non-adherent fraction on a nylon wool column, proliferated to PPD in the presence of autologous antigen presenting cells. Interestingly, addition of as low as 20% nylon wool adherent cells to these, sharply decreased the proliferation by 83%. Looking into what cells in the adherent fraction suppressed the proliferation, it was found that neither the T cell nor the macrophage enriched cell fractions of this population individually showed suppressive effect, indicating that their co-presence was necessary for the suppression. Since BCG induced granulomas resolve much faster than granulomas induced by other mycobacteria such as Mycobacterium leprae the present experimental findings add to the existing evidence that intradermal BCG vaccination influences subsequent immune responses in the host and may further stress upon its beneficial role seen in Covid-19 patients.
引用
- Vergkizi S, Nikolakakis I. Bacillus Calmette-Guérin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally. Vaccine. 2020. PMID: 33071000. doi:10.1016/j.vaccine.2020.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。